RSS

Archivi categoria: fosforo e iperfosforemia

Are There Fast-Food Choices for End-Stage Renal Disease Patients? A Look at Phosphorus and Potassium Content in Common Fast Foods – Journal of Renal Nutrition

Fast food is cheap, convenient, and common for the average American; adults consume an average of 11.3% of their daily calories from fast food.1 Fast food has become routine in most American’s lifestyles, including people with end-stage renal disease (ESRD). It is known that most fast foods are high in calories, fat, sugar, and salt because fast-food companies must provide nutritional facts at their stores and online.2 The phosphorus and potassium concentrations in foods are unfortunately not readily available to most patients or practitioners.

Sorgente: Are There Fast-Food Choices for End-Stage Renal Disease Patients? A Look at Phosphorus and Potassium Content in Common Fast Foods – Journal of Renal Nutrition

 

Management of hyperkalemia in patients with kidney disease: a position paper endorsed by the Italian Society of Nephrology. – PubMed – NCBI

PubMed comprises more than 29 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.

Sorgente: Management of hyperkalemia in patients with kidney disease: a position paper endorsed by the Italian Society of Nephrology. – PubMed – NCBI

 

Iperfosfatemia in dialisi: la scelta del chelante – GIN

Lo scenario attuale Le alterazioni del metabolismo minerale, ed in particolare l’iperfosforemia, sono riconosciute oggi fattori di rischio importanti per l’incremento della morbilità e mortalità dei pazienti affetti da malattia renale cronica, sia durante le fasi iniziali che nelle fasi più avanzate di malattia (1, 2).  Il controllo del bilancio fosforico rappresenta pertanto un punto…Continue

Sorgente: Iperfosfatemia in dialisi: la scelta del chelante – GIN

 

Phosphorus Additives and Albuminuria in Early Stages of CKD: A Randomized Controlled Trial – American Journal of Kidney Diseases

Sorgente: Phosphorus Additives and Albuminuria in Early Stages of CKD: A Randomized Controlled Trial – American Journal of Kidney Diseases

 

Phosphate – a “driver” of mortality in kidney patientsIl nuemico numero uno dei pazienti nefropatici: il fosforo

Sorgente: Phosphate – a “driver” of mortality in kidney patients

Sorgente: The role of phosphate in kidney disease : Nature Reviews Nephrology : Nature Research

 

 

Phosphate-Binding Agents in Adults With CKD: A Network Meta-analysis of Randomized Trials – American Journal of Kidney Diseases

Sorgente: Phosphate-Binding Agents in Adults With CKD: A Network Meta-analysis of Randomized Trials – American Journal of Kidney Diseases

 

Cutting Phosphorus Additives Reduces Hyperphosphatemia – Renal and Urology News

A majority of intervention patients attained serum phosphorus levels below 5.5 mg/dL, a small study verifies.

Sorgente: Cutting Phosphorus Additives Reduces Hyperphosphatemia – Renal and Urology News

 
 
%d blogger hanno fatto clic su Mi Piace per questo: